A patented, generalized drug-response foundation model trained to internalize relationships between chemical structure, tumor ...
PITTSBURGH, May 22, 2025 (GLOBE NEWSWIRE) -- Predictive Oncology Inc. (NASDAQ: POAI) moves to leverage its vast biobank of more than 150,000 heterogenous live cell tumor samples and drug response data ...
With the global biomarker discovery market valued at $14.5 billion in 2024 and projected to grow at a 19.4% CAGR through 2030, Predictive Oncology (POAI) is poised to lead in precision oncology ...
SUNNYVALE, Calif. and NEWTON, Mass., Dec. 10, 2025 (GLOBE NEWSWIRE) -- 4D Path, a company dedicated to personalizing cancer care through a novel, physics-inspired approach to predicting tumor response ...
Renovaro (RENB) announced it has entered into a binding LOI to acquire Predictive Oncology (POAI) in an all-stock transaction.By leveraging Predictive Oncology’s extensive biobank of 150,000 tumor ...
We recently published a list of Top 10 Trending AI News On Wall Street’s Radar. In this article, we are going to take a look at where Predictive Oncology Inc. (NASDAQ:POAI) stands against other top ...
Forbes contributors publish independent expert analyses and insights. David Henkin helps organizations and individuals innovate and grow. Predictive analytics has evolved from a niche discipline into ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results